US2022403313A1PendingUtilityA1
Open-top microfluidic devices and methods for simulating a function of a tissue
Est. expiryDec 4, 2035(~9.3 yrs left)· nominal 20-yr term from priority
Inventors:Antonio VaroneNorman WenDaniel LevnerRichard NovakLori McpartlinDonald E. IngberYoungjae ChoeLian LengJustin Nguyen
B01L 2300/0861C12M 23/24C12M 41/46C12M 21/08B01L 3/5027C12M 23/38C12M 23/16C12N 5/0679C12M 29/10C12N 5/069C12M 25/02C12M 3/04B01L 2300/069C12N 2502/094C12N 5/0629C12N 5/0688C12N 5/0656C12M 35/04C12M 25/14C12N 2502/1323B01L 3/502761
79
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A device for simulating a function of a tissue includes a first structure, a second structure, and a membrane. The first structure defines a first chamber. The first chamber includes a matrix disposed therein and an opened region. The second structure defines a second chamber. The membrane is located at an interface region between the first chamber and the second chamber. The membrane includes a first side facing toward the first chamber and a second side facing toward the second chamber. The membrane separates the first chamber from the second chamber.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A method of seeding cells, comprising:
(a) providing a microfluidic device comprising a first chamber and a second chamber, the second chamber separated from the first chamber by a membrane, the first chamber positioned under a removable cover; (b) removing the removable cover thereby creating an opened region over a first side of the membrane; and (c) seeding the first side of the membrane with said cells.
2 . The method of claim 1 , wherein said cells are epithelial cells.
3 . The method of claim 2 , wherein said epithelial cells are lung epithelial cells.
4 . The method of claim 1 , wherein the membrane includes endothelial cells on the opposite side of the membrane.
5 . The method of claim 4 , wherein the second chamber includes fluidics configured to supply the endothelial cells with culture fluid.
6 . The method of claim 3 , further comprising (d) culturing the lung epithelial cells submerged in culture fluid.
7 . The method of claim 3 , further comprising (e) culturing the lung epithelial cells in air without culture media.
8 . The method of claim 1 , wherein said second chamber is coupled to a channel.
9 . The method of claim 1 , wherein said first chamber comprises a gel matrix.
10 . A method of treating cells, comprising:
a) providing a microfluidic device comprising a first chamber and a second chamber, the second chamber separated from the first chamber by a membrane, the membrane including cells on a side facing the first chamber, the cells positioned under a removable cover; b) removing the removable cover thereby creating an opened region over the cells; and c) treating the cells with an agent.
11 . The method of claim 10 , wherein the agent is in an aerosol.
12 . The method of claim 10 , wherein the agent is in a liquid, gas, semi-solid, solid, or particulate form.
13 . The method of claim 10 , wherein said cells are epithelial cells.
14 . The method of claim 13 , wherein said epithelial cells are lung epithelial cells.
15 . The method of claim 10 , wherein the membrane includes endothelial cells on the opposite side of the membrane.
16 . The method of claim 15 , wherein the second chamber includes fluidics configured to supply the endothelial cells with culture fluid.
17 . The method of claim 10 , wherein said second chamber is coupled to a channel.
18 . The method of claim 10 , wherein said first chamber comprises a gel matrix.Join the waitlist — get patent alerts
Track US2022403313A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.